1. Home
  2. ASNS vs BOLT Comparison

ASNS vs BOLT Comparison

Compare ASNS & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASNS
  • BOLT
  • Stock Information
  • Founded
  • ASNS 1998
  • BOLT 2015
  • Country
  • ASNS United States
  • BOLT United States
  • Employees
  • ASNS N/A
  • BOLT N/A
  • Industry
  • ASNS Telecommunications Equipment
  • BOLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASNS Telecommunications
  • BOLT Health Care
  • Exchange
  • ASNS Nasdaq
  • BOLT Nasdaq
  • Market Cap
  • ASNS 10.9M
  • BOLT 11.5M
  • IPO Year
  • ASNS 2022
  • BOLT 2021
  • Fundamental
  • Price
  • ASNS $0.53
  • BOLT $4.71
  • Analyst Decision
  • ASNS Strong Buy
  • BOLT Buy
  • Analyst Count
  • ASNS 1
  • BOLT 4
  • Target Price
  • ASNS $5.00
  • BOLT $34.00
  • AVG Volume (30 Days)
  • ASNS 3.7M
  • BOLT 24.2K
  • Earning Date
  • ASNS 11-11-2025
  • BOLT 11-14-2025
  • Dividend Yield
  • ASNS N/A
  • BOLT N/A
  • EPS Growth
  • ASNS N/A
  • BOLT N/A
  • EPS
  • ASNS N/A
  • BOLT N/A
  • Revenue
  • ASNS $5,265,000.00
  • BOLT $4,167,000.00
  • Revenue This Year
  • ASNS N/A
  • BOLT N/A
  • Revenue Next Year
  • ASNS $198.35
  • BOLT N/A
  • P/E Ratio
  • ASNS N/A
  • BOLT N/A
  • Revenue Growth
  • ASNS N/A
  • BOLT N/A
  • 52 Week Low
  • ASNS $0.33
  • BOLT $4.42
  • 52 Week High
  • ASNS $1.78
  • BOLT $13.20
  • Technical
  • Relative Strength Index (RSI)
  • ASNS 49.52
  • BOLT 38.36
  • Support Level
  • ASNS $0.38
  • BOLT $4.42
  • Resistance Level
  • ASNS $0.75
  • BOLT $4.93
  • Average True Range (ATR)
  • ASNS 0.09
  • BOLT 0.32
  • MACD
  • ASNS -0.01
  • BOLT -0.12
  • Stochastic Oscillator
  • ASNS 29.23
  • BOLT 13.99

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: